[Federal Register Volume 90, Number 21 (Monday, February 3, 2025)]
[Presidential Documents]
[Pages 8771-8773]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02194]
Presidential Documents
Federal Register / Vol. 90 , No. 21 / Monday, February 3, 2025 /
Presidential Documents
[[Page 8771]]
Executive Order 14187 of January 28, 2025
Protecting Children From Chemical and Surgical
Mutilation
By the authority vested in me as President by the
Constitution and the laws of the United States of
America, it is hereby ordered:
Section 1. Policy and Purpose. Across the country
today, medical professionals are maiming and
sterilizing a growing number of impressionable children
under the radical and false claim that adults can
change a child's sex through a series of irreversible
medical interventions. This dangerous trend will be a
stain on our Nation's history, and it must end.
Countless children soon regret that they have been
mutilated and begin to grasp the horrifying tragedy
that they will never be able to conceive children of
their own or nurture their children through
breastfeeding. Moreover, these vulnerable youths'
medical bills may rise throughout their lifetimes, as
they are often trapped with lifelong medical
complications, a losing war with their own bodies, and,
tragically, sterilization.
Accordingly, it is the policy of the United States that
it will not fund, sponsor, promote, assist, or support
the so-called ``transition'' of a child from one sex to
another, and it will rigorously enforce all laws that
prohibit or limit these destructive and life-altering
procedures.
Sec. 2. Definitions. For the purposes of this order:
(a) The term ``child'' or ``children'' means an
individual or individuals under 19 years of age.
(b) The term ``pediatric'' means relating to the
medical care of a child.
(c) The phrase ``chemical and surgical mutilation''
means the use of puberty blockers, including GnRH
agonists and other interventions, to delay the onset or
progression of normally timed puberty in an individual
who does not identify as his or her sex; the use of sex
hormones, such as androgen blockers, estrogen,
progesterone, or testosterone, to align an individual's
physical appearance with an identity that differs from
his or her sex; and surgical procedures that attempt to
transform an individual's physical appearance to align
with an identity that differs from his or her sex or
that attempt to alter or remove an individual's sexual
organs to minimize or destroy their natural biological
functions. This phrase sometimes is referred to as
``gender affirming care.''
Sec. 3. Ending Reliance on Junk Science. (a) The
blatant harm done to children by chemical and surgical
mutilation cloaks itself in medical necessity, spurred
by guidance from the World Professional Association for
Transgender Health (WPATH), which lacks scientific
integrity. In light of the scientific concerns with the
WPATH guidance:
(i) agencies shall rescind or amend all policies that rely on WPATH
guidance, including WPATH's ``Standards of Care Version 8''; and
(ii) within 90 days of the date of this order, the Secretary of Health and
Human Services (HHS) shall publish a review of the existing literature on
best practices for promoting the health of children who assert gender
dysphoria, rapid-onset gender dysphoria, or other identity-based confusion.
(b) The Secretary of HHS, as appropriate and
consistent with applicable law, shall use all available
methods to increase the quality of data to guide
practices for improving the health of minors with
gender dysphoria, rapid-onset gender dysphoria, or
other identity-based confusion, or who otherwise seek
chemical or surgical mutilation.
[[Page 8772]]
Sec. 4. Defunding Chemical and Surgical Mutilation. The
head of each executive department or agency (agency)
that provides research or education grants to medical
institutions, including medical schools and hospitals,
shall, consistent with applicable law and in
coordination with the Director of the Office of
Management and Budget, immediately take appropriate
steps to ensure that institutions receiving Federal
research or education grants end the chemical and
surgical mutilation of children.
Sec. 5. Additional Directives to the Secretary of HHS.
(a) The Secretary of HHS shall, consistent with
applicable law, take all appropriate actions to end the
chemical and surgical mutilation of children, including
regulatory and sub-regulatory actions, which may
involve the following laws, programs, issues, or
documents:
(i) Medicare or Medicaid conditions of participation or conditions for
coverage;
(ii) clinical-abuse or inappropriate-use assessments relevant to State
Medicaid programs;
(iii) mandatory drug use reviews;
(iv) section 1557 of the Patient Protection and Affordable Care Act;
(v) quality, safety, and oversight memoranda;
(vi) essential health benefits requirements; and
(vii) the Eleventh Revision of the International Classification of Diseases
and other federally funded manuals, including the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition.
(b) The Secretary of HHS shall promptly withdraw
HHS's March 2, 2022, guidance document titled ``HHS
Notice and Guidance on Gender Affirming Care, Civil
Rights and Patient Privacy'' and, in consultation with
the Attorney General, issue new guidance protecting
whistleblowers who take action related to ensuring
compliance with this order.
Sec. 6. TRICARE. The Department of Defense provides
health insurance, through TRICARE, to nearly 2 million
individuals under the age of 18. As appropriate and
consistent with applicable law, the Secretary of
Defense shall commence a rulemaking or sub-regulatory
action to exclude chemical and surgical mutilation of
children from TRICARE coverage and amend the TRICARE
provider handbook to exclude chemical and surgical
mutilation of children.
Sec. 7. Requirements for Insurance Carriers. The
Director of the Office of Personnel Management, as
appropriate and consistent with applicable law, shall:
(a) include provisions in the Federal Employee
Health Benefits (FEHB) and Postal Service Health
Benefits (PSHB) programs call letter for the 2026 Plan
Year specifying that eligible carriers, including the
Foreign Service Benefit Plan, will exclude coverage for
pediatric transgender surgeries or hormone treatments;
and
(b) negotiate to obtain appropriate corresponding
reductions in FEHB and PSHB premiums.
Sec. 8. Directives to the Department of Justice. The
Attorney General shall:
(a) review Department of Justice enforcement of
section 116 of title 18, United States Code, and
prioritize enforcement of protections against female
genital mutilation;
(b) convene States' Attorneys General and other law
enforcement officers to coordinate the enforcement of
laws against female genital mutilation across all
American States and Territories;
(c) prioritize investigations and take appropriate
action to end deception of consumers, fraud, and
violations of the Food, Drug, and Cosmetic Act by any
entity that may be misleading the public about long-
term side effects of chemical and surgical mutilation;
[[Page 8773]]
(d) in consultation with the Congress, work to
draft, propose, and promote legislation to enact a
private right of action for children and the parents of
children whose healthy body parts have been damaged by
medical professionals practicing chemical and surgical
mutilation, which should include a lengthy statute of
limitations; and
(e) prioritize investigations and take appropriate
action to end child-abusive practices by so-called
sanctuary States that facilitate stripping custody from
parents who support the healthy development of their
own children, including by considering the application
of the Parental Kidnaping Prevention Act and recognized
constitutional rights.
Sec. 9. Enforcing Adequate Progress. Within 60 days of
the date of this order, the heads of agencies with
responsibilities under this order shall submit a
single, combined report to the Assistant to the
President for Domestic Policy, detailing progress in
implementing this order and a timeline for future
action. The Assistant to the President for Domestic
Policy shall regularly convene the heads of agencies
with responsibilities under this order (or their
designees) to coordinate and prepare for this
submission.
Sec. 10. Severability. If any provision of this order,
or the application of any provision to any person or
circumstances, is held to be invalid, the remainder of
this order and the application of any of its other
provisions to any other persons or circumstances shall
not be affected thereby.
Sec. 11. General Provisions. (a) Nothing in this order
shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or
the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget
relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with
applicable law and subject to the availability of
appropriations.
(c) This order is not intended to, and does not,
create any right or benefit, substantive or procedural,
enforceable at law or in equity by any party against
the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any
other person.
(Presidential Sig.)
THE WHITE HOUSE,
January 28, 2025.
[FR Doc. 2025-02194
Filed 1-31-25; 8:45 am]
Billing code 3395-F4-P